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Review of the book “RNA/DNA and Cancer” written by Joseph G. Sinkovics
(Springer International Publishing, Switzerland, 2016, ISBN 978-3-319-22278-3,
DOI 10.1007/978-3-319-22279-0)
The author of this book, Joseph G. (Jo´zsef Géza) Sinkovics, was born in
Budapest, Hungary. He graduated from the Medical Faculty of Péter Pázmány
University with summa cum laude medical doctorate degree in 1948. He started
working as an adjunct professor at the University Institute of Microbiology and as
a senior virologist and board-certiﬁed clinical pathologist at the State Institute of
Hygiene in Budapest. After the Hungarian Uprising of 1956, Sinkovics had to
leave the country; he went to the United States, where he was sponsored by Albert
Sabin for a Rockefeller Fellowship. From 1962, he continued working at the M.D.
Anderson Hospital, where he later was elevated to the rank of professor of
medicine. He became the clinical chief of the united Sarcoma-Melanoma Clinics
and In-patient Services at the M.D. Anderson Hospital; and worked as the Chief of
the research laboratories, Section of Clinical Tumor Virology & Immunology,
within the Department of Medicine. In the Section, during the mid-1960s,
Sinkovics recognized a naturally formed murine hybridoma, in which leukemia
virus-producer lymphoma cells fused with speciﬁc antiviral antibody-producer
normal plasma cells. He published this ﬁrst described phenomenon in January
1970 in the journal The Lancet. In the late 1960s, Sinkovics recognized that cancer
cells of patients of both genders could be killed by large granular lymphocytes
derived from his own blood. Those patients with cancer, who received an
autologous viral oncolysate vaccine (produced at the Section in an institutionally
approved protocol), increased producing this type of cells in their blood. In the
early 1980s, Sinkovics was offered the directorship of the outstanding St. Joseph’s
Hospital of Tampa, FL, to its newly constructed free-standing 30 beds cancer
hospital with research facilities. He was also invited to the University of South
Florida College of Medicine external professorial teaching staff position. He
published the textbook Sinkovics J.G.: Medical Oncology – An Advanced Course,
Marcel Dekker, New York (second edition in 1986) and in 2008 his superbly
illustrated monograph on “Cytolytic Immune Lymphocytes” by Schenk Buch-
verlag, Passau/Budapest.
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The retired professor Sinkovics, investigator and clinician, introduces his
readers to his unique and inmost views on cancer biology. The work is excellent,
citing plenty of convincing references and illustrations. The tables and the ﬁgures
cross-refer to one another and cite the most important literature.
The ﬁrst eukaryotes of the ancient Earth acquired a special way to outlast
and expand, using their unique life survival pathways, an independent immortal-
ized manner, as Sinkovics points out in the summary of the book:
The ancestors of the oncogenes were the “cell survival pathway” genes of the ﬁrst
unicellular life forms; these genes remain conserved in their extant descendants.
The beta-catenin-dependent Wnt pathway encodes the body axes in unicellular and
early multicellular eukaryotes (choanoﬂagellates; Ciona; Nematostella, Spon-
giae). In the human genome, the Wnt pathway is a proto-oncogene.
The derivatives of these primordial genes, for example the achaete-scute genes of the
amphioxus (Branchiostoma ﬂoridae) encode now neuroblastomas (the esthesioneur-
oblastoma) and transform adenocarcinoma cells into highly resistant neuroectoder-
mal/neuroendocrine malignant cellular entities. Proteins essential for life in the
archaea, prokaryota and unicellular eukaryota rise in selected single cells of the multi-
cellular host to induce, promote, or chaperone their “malignant transformation”.
The ancient cell survival pathways evolved in time in order to ﬁt into
complex multicellular hosts. The human cerebral cortex recognizes the oncogenic
pathways for rejection with congenial means of chemoimmunotherapy as enemies
of the organized cell communities. Or, the complex hosts may support the
transformed cells, as if they were immortalized life forms for the eventual
population of the Universe.
There is a signiﬁcant difference between the oncogenesis indicated by
exogenous pathogens and the endogenously generated process. The conserved
ancient cell survival pathways triggered by exogenous viruses, bacteria or parasites,
activate resistance, and defensive reactions of the host. On the contrary, endoge-
nously activated by ancient proviruses preserved in the host genome, like the LINE
elements, in some selected cells, the cell survivor pathways are reactivated
endogenously by the RNA/DNA complex. These cells use mimicry to protect and
maintain themselves, as the host organ is evolutionarily trained to act with
immunological tolerance toward them. This way, the human host not only tolerates,
but also actively supports this mechanism of oncogenesis. This novelty is described
and explained in great detail in this book, like never before in the literature.
It is known that malignantly transformed human cells are maintained under
laboratory circumstances as immortalized cultures even after storage in liquid
nitrogen. It indicates that these cells may be even capable of reorganizing to
multicellular colonies if the environmental conditions are appropriate.
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Although originally the process of oncogenesis served for the rescue of
cellular life, it leads to uncontrolled transformation in the human host. To cure this
error and its consequences, all kinds of therapeutic methods, the human cerebral
cortex has ever invented, must be applied. The diversity of these techniques is well
assumed in this volume:
Avoid mutagenic toxic exposures and utilize the consumption of natural substances
(phytochemicals) that prevent random and even inherent genomic mutations.
Manipulate the epigenome in favour of the tumour suppressor genes. Laboratory-
made miRs will neutralize the mRNAs of the oncoproteins; circulating oncoprotein
kinases will be marked for ubiquitination by small molecular inhibitors ﬁtted into
their speciﬁc domains (their “side pockets”); monoclonal antibody-complexed
oncoproteins will be naturally eliminated (by ubiquitination); tumour suppressor
genes will be vectored by lentiviruses; and tumour masses will be dissolved by
targeted small molecular inhibitors or oncolytic viruses. Avoid indiscriminate
attacks on the genomes; target the oncogene by highly specialized gene therapy;
target the oncoprotein by speciﬁc immunotherapy; and combine these modalities
of treatment. Use inhibitory monoclonal antibodies to release NK and immune
T cells from the evolutionarily installed checkpoints (CTLA4; PD1) for the attack
on malignantly transformed cells masquerading as ‘self’. Intensify CAR therapy for
solid tumours. The multicellular host is to be rescued intact, not just as a
disorganized cell community preserved in a tissue culture ﬂask.
Working for many years as medical oncologist, Sinkovics not only con-
quered the malignant disease when accomplishing complete remissions, but also
experienced devastating failures when relapses occurred. The increasing numbers
of successful treatments helped him to overcome the difﬁcult times and gave force
to work tirelessly on therapeutics with fewer side effects.
In this huge and complex work, only a few editorial errors remain. The
legends of some ﬁgures are explained in full detail not customarily in the text, but
separately in the two (most useful) appendices. The index is missing a few
important passages. Some pre-digital era illustrations are not of ﬁrst-class quality.
The work is unique, unparalleled in the literature, it is an excellent teaching
material to advanced students and provides a view of life and cancer never
described before.
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